Court of Justice of the European Union · EU
Judgment of the General Court (Eighth Chamber) of 2 September 2026.#Ferring Pharmaceuticals A/S v European Commission.#Medicinal products for human use – Generic medicinal products – Marketing authorisation for the medicinal product for human use Degarelix Accord – degarelix acetate – Lack of bioequivalence study with the reference medicinal product – Article 10(1) and (2) of Directive 2001/83/EC – Manifest error of assessment – Principle of good administration.#Case T-12/24.
- Identifier
- CELEX 62024TJ0012
- Status
- decided
- Decided
- 2 September 2026
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:62024TJ0012
- Source provider
- eurlex
- Retrieved
- 2026-09-05T09:54:25.186Z
Identifier
- CELEX: 62024TJ0012
Direct relationships
No labelled cross-repository relations yet.